NF-κB/IκB

Ceramide 3, a bioactive sphingolipid, plays a crucial role in cellular processes by regulating apoptosis, cell differentiation, and the proliferation of smooth muscle cells. This compound functions by inhibiting the mitochondrial respiratory chain and suppressing the expression of allergic cytokines such as IL-4 and TNF-α, as well as transcription factors like c-Jun and NF-κB in histone-stimulated mouse skin tissue. Ceramide 3 is utilized in various biochemical assays and has applications in dermatological research, particularly in studies related to skin barrier function and hydration.

Ceramide 3-d3 (N-Stearoyl phytosphingosine-d3) is a deuterated form of Ceramide 3, a bioactive sphingolipid notably present in the stratum corneum of Saccharomyces cerevisiae, wheat grain, and mammalian epidermis. With a phytosphingosine backbone linked to a C18 fatty acid chain, Ceramide 3-d3 plays a crucial role in regulating apoptosis and cell differentiation, while also supporting smooth muscle cell proliferation and inhibiting the mitochondrial respiratory chain. Furthermore, it suppresses the expression of pro-inflammatory cytokines IL-4 and TNF-α, as well as transcription factors c-Jun and NF-κB in histone-stimulated mouse skin tissue, making it valuable for research in skin health and inflammation.

3-Aminosalicylic acid is a key impurity associated with the synthesis of 5-Aminosalicylic acid, a known agonist of PPARγ and an inhibitor of p21-activated kinase 1 (PAK1) and NF-κB. This compound is primarily used in research related to inflammatory bowel diseases such as Crohn's disease and ulcerative proctitis. Its role in modulating these pathways makes it significant for studies focused on therapeutic interventions and drug development in gastrointestinal conditions.

Methyl cis-15-tetracosenoate, also known as methyl nervonate, is the methyl ester of nervonic acid, a monounsaturated fatty acid with significant biological activity. It is known to inhibit the NF-κB signaling pathway, demonstrating anti-inflammatory properties. This compound is valuable in research related to neurodegenerative diseases, aiding in the understanding of cellular mechanisms and potential therapeutic approaches.

(Z)-Onjisaponin B is a drug derivative that primarily targets the inhibition of NF-κB p65. This natural product, derived from Polygala tenuifolia, exhibits significant biological activity by enhancing autophagy and promoting the degradation of mutant α-synuclein and huntingtin. Additionally, (Z)-Onjisaponin B reduces β-amyloid (Aβ) production and mitigates radiation-induced cell apoptosis, while also demonstrating antioxidant and anti-inflammatory properties. Its applications extend to research in neurological diseases and radiation injuries, with the ability of its metabolite, tenuifolin (TF), to penetrate the blood-brain barrier.

(Z)-Neochlorogenic acid is a natural polyphenolic compound that targets inflammatory pathways. It exhibits significant inhibition of pro-inflammatory cytokines TNF-α and IL-1β, along with suppression of iNOS and COX-2 protein expression. Furthermore, (Z)-Neochlorogenic acid downregulates phosphorylated NF-κB p65 and p38 MAPK activation, making it a valuable reagent for research in inflammation and related diseases.

Cucurbitacin V is a natural triterpene that primarily targets the signaling pathways involving the NF-κB pathway and various protein kinases. It exhibits significant anti-inflammatory, anticancer, and antiproliferative activities, making it a valuable compound in cancer research and the study of inflammatory diseases. This triterpene is often used to investigate the mechanisms of apoptosis and cell cycle regulation in various cancer cell lines.

HHQ16 is an orally active compound designed to combat heart failure. Its primary mechanism involves the targeted degradation of lnc4012 and lnc9456, which leads to the reversal of infarction-induced hypertrophy. By antagonizing the effects on the G3BP2/NF-κB signaling pathway, HHQ16 demonstrates significant potential for research applications related to myocardial dysfunction and heart failure therapeutics.

D-Ribose-1,2-13C2 is a stable isotope-labeled form of D-Ribose, serving as a vital component in energy metabolism. It acts as a sugar moiety of ATP and is commonly utilized in metabolic therapy for conditions such as chronic fatigue syndrome and cardiac energy metabolism. Additionally, D-Ribose is involved in protein glycation processes and induces NF-κB-mediated inflammation through a RAGE-dependent mechanism, making it a valuable tool for various biological research applications.

Vanillic acid-13C6 is an isotope-labeled compound targeting metabolic studies and biological research. This stable isotope of vanillic acid, a naturally occurring flavoring agent, is known for its ability to inhibit NF-κB activation, presenting anti-inflammatory and antimicrobial properties. It is widely utilized in biological assays, metabolic tracking, and flavor profiling studies to elucidate biochemical pathways and assess the physiological effects of vanillic acid in various systems.

(Rac)-Salvianic acid A is a racemic mixture of the phenolic compound Salvianic acid A, which primarily targets the Nrf2 pathway. It is known to activate Nrf2 and induce the expression of HO-1 while inhibiting the NF-κB pathway. This compound exhibits significant biological activities, including antioxidant, anti-apoptotic, and anti-inflammatory effects, and is relevant for research into conditions such as COVID-19, cardiovascular, and cerebrovascular diseases.

Gabexate mesylate is a competitive proteasome inhibitor, primarily targeting serine proteinases such as thrombin and Factor Xa. It exhibits diverse biological activity, including anticoagulant effects by modulating thrombin activity and anti-inflammatory properties through the inhibition of NF-κB and proinflammatory cytokines. Gabexate mesylate is commonly utilized in research focused on pancreatitis and disseminated intravascular coagulation, making it a valuable reagent for studies in hemostasis and inflammation.

Erdosteine functions as a bacterial inhibitor by inhibiting lipopolysaccharide (LPS)-induced activation of NF-κB. This compound exhibits muco-modulatory, anti-bacterial, anti-inflammatory, and antioxidant properties. Erdosteine is primarily utilized in research applications focused on respiratory disorders and inflammation, supporting the study of therapeutic interventions in these areas.

Cimifugin is an anti-allergic agent derived from the herb Cimicifuga racemosa. It exhibits properties that suppress allergic inflammation by modulating key factors derived from epithelial cells and regulating tight junction integrity. Additionally, Cimifugin demonstrates a capacity to reduce the migration and chemotaxis of RAW264.7 macrophage cells while inhibiting the release of inflammatory mediators and the activation of MAPK and NF-κB signaling pathways triggered by LPS. This compound is valuable for research into mechanisms of allergic responses and inflammatory conditions.

Stachydrine hydrochloride is an endogenous metabolite that primarily targets the NF-κB signaling pathway. It exhibits notable anti-hypertrophic activities, making it a candidate for research into therapeutic applications for cardiovascular diseases. Its ability to modulate inflammatory responses may provide valuable insights for studies focused on hypertensive conditions and related cardiovascular disorders.

Isoquercitrin is a potent nitric oxide synthase inhibitor with significant antioxidant and anti-inflammatory properties. This naturally occurring polyphenol exerts protective effects against ethanol-induced hepatotoxicity and oxidative stress, primarily through the activation of the Nrf2/ARE signaling pathway. Additionally, Isoquercitrin modulates the expression of nitric oxide synthase 2 (NOS2) via the nuclear factor-κB (NF-κB) regulatory mechanism. Due to its high bioavailability and low toxicity, Isoquercitrin presents potential applications in research on metabolic disorders and the prevention of birth defects in diabetic pregnancies.

Gomisin J is a lignan derived from Schisandra chinensis that primarily acts as a calcium channel activator. It enhances nitric oxide bioavailability through eNOS activation and regulates lipid metabolism via the AMPK pathway. Additionally, Gomisin J exhibits anti-inflammatory effects by inhibiting fetuin-A and NF-κB, while its activation of Nrf2/HO-1 boosts antioxidant capacity. This compound is relevant for studies focused on hypertension, non-alcoholic fatty liver disease, and cerebral ischemia-reperfusion injury.

Benzoyloxypaeoniflorin is a potent tyrosinase inhibitor derived from the root of Paeonia suffruticosa, exhibiting an IC50 value of 0.453 mM against mushroom tyrosinase. Additionally, it functions as an NF-κB inhibitor, contributing to enhanced blood circulation by inhibiting platelet aggregation and blood coagulation. This compound is of significant interest in research applications focused on skin disorders and inflammation.

Praeruptorin A is an anti-inflammatory compound derived from Peucedanum praeruptorum. It demonstrates significant anti-inflammatory activity by inhibiting NF-κB activation, which is crucial for mediating inflammatory responses. This compound is valuable in research applications focused on inflammation-related signaling pathways and the development of anti-inflammatory therapies.

Flaconitine is a potent inhibitor of the NF-κB signaling pathway. This compound has been shown to effectively block the activation of NF-κB, thus modulating inflammatory responses. Flaconitine is widely used in research focused on immunology, cancer biology, and studies involving inflammatory diseases. Its ability to regulate gene expression through NF-κB inhibition makes it a valuable tool for investigating cellular signaling and therapeutic pathways.

EUK-134 is a synthetic superoxide dismutase (SOD) mimetic with catalase activity, primarily targeting oxidative stress in cellular environments. This compound exhibits mitoprotective antioxidant properties, effectively reducing ischemia-reperfusion-induced damage in rat kidneys. In H9C2 cardiac cells, EUK-134 decreases the expression levels of NF-κB, malondialdehyde (MDA), and protein carbonylation, making it a valuable tool for research on oxidative stress and cellular protection mechanisms.

Myristic acid is a saturated 14-carbon fatty acid that acts as an endogenous metabolite. It exhibits anti-inflammatory activity primarily through the NF-κB signaling pathway. In addition to its anti-inflammatory properties, myristic acid also demonstrates antibacterial and analgesic effects, making it valuable for research in inflammation, immunity, and pain management.

Tolterodine is an mAChR inhibitor that competitively binds to acetylcholine, leading to a reduction in sympathetic excitation and inhibition of involuntary bladder muscle contractions. It is known to restore the Nrf2/NF-κB signaling pathway, providing protection against inflammatory responses and ferroptosis. Additionally, Tolterodine mitigates LPS-induced reactive oxygen species production and lipid oxidation, making it valuable for research in urinary tract infections and overactive bladder conditions.

Methylprednisolone succinate sodium is a prodrug of methylprednisolone and acts as a glucocorticoid agonist. It exhibits significant immunosuppressant and anti-inflammatory properties by binding to cytosolic glucocorticoid receptors, which facilitates the modulation of target gene transcription. This compound influences the expression of key proteins such as Bax, Bcl-2, occludin, and ZO-1, while also attenuating TLR4/NF-κB signaling, suppressing proinflammatory cytokine production, and inhibiting immune cell activation. Methylprednisolone succinate sodium is valuable for research related to intracranial hemorrhage, rheumatoid arthritis, multiple sclerosis, and various inflammatory conditions.

RN-0001 is a potent inhibitor of cyclophilins, specifically demonstrating Ki values of 4.1 nM and 12.0 nM against Cyclophilin A (CypA) and Cyclophilin D (CypD), respectively. By directly binding to CypD, RN-0001 effectively inhibits its peptidyl-prolyl cis-trans isomerase activity, preventing mitochondrial permeability transition pore opening. This compound enhances mitochondrial function, diminishes reactive oxygen species (ROS) production, and downregulates lipogenic marker expression. Additionally, RN-0001 inhibits NF-κB p65 nuclear translocation and reduces the release of activated caspase-3 and cytochrome c, making it a valuable tool for investigating alcohol-associated liver disease.

HDAC2-IN-3 is a selective HDAC2 inhibitor with an IC50 of 14 nM, capable of crossing the blood-brain barrier. This compound effectively upregulates histone acetylation levels both in cultured cells and in vivo, and has been shown to enhance long-term potentiation (LTP) in the hippocampus. HDAC2-IN-3 is valuable for research applications focused on neurodegenerative disorders, particularly Alzheimer's disease.

HDAC8-IN-16 is a selective inhibitor of histone deacetylase 8 (HDAC8), exhibiting an IC50 of 0.16 μM. It has been shown to induce apoptosis in various cell lines, trigger G2/M phase cell cycle arrest, and moderately inhibit cancer cell proliferation. This compound is particularly relevant for research applications related to colorectal cancer, providing valuable insights into the therapeutic potential of HDAC8 modulation.

HDAC6-IN-78 is a highly selective inhibitor of histone deacetylase 6 (HDAC6), exhibiting an IC50 of 24 nM. This compound demonstrates specificity by showing no significant activity against other HDAC isoforms. HDAC6-IN-78 is valuable for research applications focused on studying the role of HDAC6 in cellular processes, including neurodegenerative diseases and cancer.

NCT-10b is a selective inhibitor of HDAC6, primarily targeting this enzyme to influence cellular processes. It facilitates α-tubulin acetylation while having minimal effect on histone H4 acetylation. NCT-10b is applicable in research focused on multiple myeloma, providing insights into the mechanisms of this hematological malignancy and potential therapeutic strategies.

4-Phenylcinnamic acid is a weak inhibitor of HDAC2, exhibiting an IC50 value greater than 5 μM. This compound has demonstrated moderate activity in inhibiting cell growth in various tumor cell lines. Its role as an HDAC2 inhibitor makes it a useful tool for exploring the effects of histone deacetylation in cancer research and related fields.

PSP-0119 is a highly selective PROTAC degrader targeting IRAK4, demonstrating an IC50 of 2.83 nM. This compound effectively inhibits IRAK4 kinase activity, NF-κB signaling, and IL-1β-induced IRAK4 phosphorylation. Notably, PSP-0119 induces degradation of IRAK4 specifically in FLT3-mutant acute myeloid leukemia (AML) cell lines while sparing FLT3-wild-type AML cells and normal bone marrow. It serves as a valuable tool for research into the mechanisms underlying AML, particularly in targeting aberrant IRAK4 activity.

Rhynchophylline is an alkaloid compound characterized as an NF-κB inhibitor. It exhibits significant biological activity with potential applications in anti-inflammatory and neuroprotective research. This compound is derived from Uncaria rhynchophyllum and is of interest for studies investigating the modulation of inflammatory pathways and neuronal protection mechanisms.